radspherin
spdr s&p biotech,ishares biotechnology,oncoinvent
['radspherin ', 'rectal', 'colorectal', '$ibb', 'oncoinvent', '$xbi']
oncoinvent presents positive safety and efficacy results of radspherin in colorectal cancer patients at 2023 asco annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt